Charles River Laboratorie...

NYSE: CRL · Real-Time Price · USD
157.00
1.20 (0.77%)
At close: Aug 15, 2025, 9:59 AM

Charles River Laboratories International Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 28, 2024 Dec 30, 2023 Dec 31, 2022 Dec 25, 2021
Revenue
4.05B 4.13B 3.98B 3.54B
Cost of Revenue
2.72B 2.63B 2.51B 2.21B
Gross Profit
1.33B 1.5B 1.46B 1.33B
Operating Income
227.35M 617.26M 650.98M 589.86M
Interest Income
8.57M 5.2M 780K 652K
Pretax Income
93.11M 581.28M 622.99M 480.71M
Net Income
10.3M 474.62M 486.23M 390.98M
Selling & General & Admin
751M 747.86M 665.1M 619.92M
Research & Development
n/a n/a n/a n/a
Other Expenses
353.47M 137.44M 146.58M 124.86M
Operating Expenses
1.1B 885.29M 811.68M 744.78M
Interest Expense
126.29M 136.71M 59.29M 73.91M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
3.82B 3.51B 3.33B 2.95B
Income Tax Expense
67.82M 100.91M 130.38M 81.87M
Shares Outstanding (Basic)
51.38M 51.23M 50.81M 50.29M
Shares Outstanding (Diluted)
51.63M 51.45M 51.3M 51.42M
EPS (Basic)
0.20 9.27 9.57 7.77
EPS (Diluted)
0.20 9.22 9.48 7.60
EBITDA
581.14M 1.03B 986.15M 854.29M
EBIT
219.4M 717.99M 682.28M 554.62M
Depreciation & Amortization
361.74M 314.12M 303.87M 265.54M